BioXcel Therapeutics
BTAI
BTAI
48 hedge funds and large institutions have $3.21M invested in BioXcel Therapeutics in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
18% less call options, than puts
Call options by funds: $23K | Put options by funds: $28K
41% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 17
Holders
48
Holding in Top 10
–
Calls
$23K
Puts
$28K
Top Buyers
| 1 | +$1.61M | |
| 2 | +$473K | |
| 3 | +$18.1K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$12.4K |
| 5 |
HF
HRT Financial
New York
|
+$9K |
Top Sellers
| 1 | -$19.4K | |
| 2 | -$16K | |
| 3 | -$15.7K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$11.5K |
| 5 |
Jane Street
New York
|
-$9.71K |